Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Bead-Based Assay Kits to Boost Metabolic and Hormone Research

By BiotechDaily International staff writers
Posted on 28 Jul 2014
Bio-Rad\'s Bio-Plex Pro RBM Magnetic Bead-Based Assay
The Bio-Plex Pro RBM Magnetic Bead-Based Assay (Photo courtesy of BIO-RAD LABORATORIES)
A new line of magnetic bead, microtiter plate-based metabolic assay kits is now available for use by biotech and other life science researchers.

The Bio-Rad Laboratories, Inc. (Hercules, CA, USA) Bio-Plex Pro RBM Human Metabolic and Hormone Assay line comprises kits for the analysis of seven panels of highly relevant biomarkers involved in diabetes, obesity, metabolic syndrome, cardiovascular disease (CVD), and hormonal control of metabolism and reproductive organs. The kits were developed in partnership with Myriad RBM, Inc., (Austin, TX, USA).

In the standard format, each kit contains one 96-well microtiter plate, magnetic capture beads, detection antibodies, standards, two-level controls, diluent, buffers, streptavidin-PE, and plate seals for the detection of up to eight human metabolic markers.

The assays are built on a magnetic bead platform, which allows data to be reported within three and a half hours. The kit format enables robust quantification of multiple proteins in human serum, plasma, and cell culture media samples. Kits are offered for research involving gut hormones and adipokines, pituitary hormones, diabetes (type I and type II), metabolic syndrome, obesity, CVD, and inflammation.

The Bio-Plex Pro RBM Human Metabolic and Hormone Assay line of kits is compatible with the Bio-Plex 100/200, Bio-Plex 3D, and Bio-Plex MAGPIX analytical platforms, as well as all other Luminex-based xMAP instruments and software.

Related Links:
Bio-Rad Laboratories, Inc.
Myriad RBM, Inc.




Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to BiotechDaily.com and get complete access to news and events that shape the world of biotechnology.
Free digital version edition of Bio Research International sent by email on regular basis
Free print version of Bio Research International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of Bio Research International in digital format
Free Bio Research International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?


SLAS - Society for Laboratory Automation and Screening
RANDOX LABORATORIES
BIOSIGMA S.R.L.
comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: A 3-dimensional picture reveals how the antibodies in the experimental drug Zmapp bind to Ebola virus (Photo courtesy of the Scripps Research Institute).

Electron Microscope Imaging Shows How Experimental Anti-Ebola Drug Works

Electron microscope imaging has revealed how the experimental drug ZMapp binds to the Ebolavirus and provides insights into how the drug prevents growth of the pathogen. ZMapp, which was developed by... Read more

Drug Discovery

view channel

Omega 3 Found to Improve Behavior in Children with ADHD

Supplements of the fatty acids omega 3 and 6 can help children and adolescents who have a specific kind of have attention deficit hyperactivity disorder (ADHD). Moreover, these findings indicate that a customized cognitive training program can improve problem behavior in children with ADHD. Statistics show that 3%–6%... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

Two Industry Partnerships Initiated to Fuel Neuroscience Research

Faster, more complex neural research is now attainable by combining technology from two research companies. Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.